(1)
Assessing the Clinical Outcomes of Voxelotor Treatment in Patients With Sickle Cell Disease. Int J Appl Sci Biotechnol 2024, 12 (1), 46-53. https://doi.org/10.3126/ijasbt.v12i1.64057.